Evidence map›Paper›PMID 28073916›Full record

ArticleThe Journal of biological chemistry2017

Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation.

Emiko Shiba, Kumi Izawa, Ayako Kaitani, Masamichi Isobe, Akie Maehara, Koichiro Uchida, Keiko Maeda, Nobuhiro Nakano, Hideoki Ogawa, Ko Okumura and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. The CD300e molecule in mice is an immune-activating receptor.The Journal of biological chemistry · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Emiko ShibaFrom the Atopy Research Center and.
Kumi IzawaFrom the Atopy Research Center and.
Ayako KaitaniFrom the Atopy Research Center and.
Masamichi IsobeFrom the Atopy Research Center and.
Akie MaeharaFrom the Atopy Research Center and.
Koichiro UchidaFrom the Atopy Research Center and.
Keiko MaedaFrom the Atopy Research Center and.
Nobuhiro NakanoFrom the Atopy Research Center and.
Hideoki OgawaFrom the Atopy Research Center and.
Ko OkumuraFrom the Atopy Research Center and.
Toshio Kitamurathe Division of Cellular Therapy/Division of Stem Cell Signaling, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan kitamura@ims.u-tokyo.ac.jp.
Toshiaki ShimizuFrom the Atopy Research Center and.
Jiro KitauraFrom the Atopy Research Center and j-kitaura@juntendo.ac.jp.
The University of Tokyo · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LPS triggers inflammatory responses; however, the negative regulation of LPS responses

Indexed as

AnimalsCeramidesChemotaxis, LeukocyteDermatitisLipopolysaccharidesMast CellsMiceMice, Inbred C57BLMice, KnockoutNeutrophilsReceptors, ImmunologicCeramidesCLM-1 protein, mouseLipopolysaccharidesReceptors, Immunologicinflammationlipopolysaccharide (LPS)mast cellneutrophilreceptor

Identifiers

PMID28073916
PMCPMC5314187
OpenAlexW2569247756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.